Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418269 | PMC |
http://dx.doi.org/10.2340/actadv.v104.40967 | DOI Listing |
Acta Derm Venereol
September 2024
Ankara Etlik City Hospital, Department of Pathology, Ankara,Turkey.
Cureus
August 2023
Department of Neurology, Hacettepe University, Ankara, TUR.
Teriflunomide is a once-daily oral immunomodulatory disease-modifying treatment for multiple sclerosis (MS). Skin reactions are an infrequent side effect of teriflunomide. Here, we present the case of a 52-year-old female patient with ankylosing spondylitis who was consulted for demyelinating lesions and limb weakness.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!